Document is current
Any future updates will be listed below
-
Authors
Elterman, Dean https://orcid.org/0000-0003-1507-7783
Perscky, Ingrid
Urena, Ruben
Codelia-Anjum, Alia
Kadlec, Adam
Chughtai, Bilal https://orcid.org/0000-0002-0515-2578
-
Funding
Funding for this research was provided by:
Rivermark Medical, Inc.
- License Information
-
More Information
Article History
Received: 10 December 2024
Revised: 1 April 2025
Accepted: 9 May 2025
First Online: 21 May 2025
Competing interests
: AK is the president and CEO of Rivermark Medical, Inc. DE is a consultant for Olympus, Boston Scientific, and Procept BioRobotics. BC is a consultant for Olympus, Boston Scientific, Femselect, ARMs, Prodeon Medical, Sumitomo, Zenflow, and Teleflex. He is an advisor for Promaxo, Bright Uro, COSM, and Soundable. The other authors declare that they have no competing interest.
: This study was approved by the Comite de Bioetica de la Investigacion del Instituto Commemorativo Gorgas (CBI-ICGES) and the Panama National Health Ministry (registration number: RESESGIS: #2491). All methods were performed in accordance with the approved protocol, relevant guidelnes and regulations, and the principles of the Declaration of Helsinki. All participants provided informed written consent prior to enrollment in the study.
: All study participants provided informed written consent prior to study enrollment. No identifiable images or personal data of participants are published in this manauscript.
